Ajouter aux favoris   Ajouter cette page à mon bookmark --- SOCIAL BOOKMARKING --- Digg Furl del.icio.us Netscape

Germany Wound Care Management Medical Equipment Industry Report

Summary

This report is an essential source for in-depth information and data relating to Germany wound care management medical equipment medical equipment market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and latest news, financial deals and pipeline products information of each of the key sub-segments of the wound care management in Germany

Scope

• The report provides sector information broken down into detailed categories and segments in country.
• Total revenues, products sold, end users, and average pricing.
• Market shares of all the key competitors.
• Key pipeline products that are set to shape the market, broken down by sector.
• Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
• Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
• Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
• Key mergers and acquisitions, partnerships, private equity investments and IPOs.
• Customer, hospitals and physicians data.

Reasons to buy

• Gain a strong understanding of the industry at a global level, with break downs for the country
• Evaluate and compare the attractiveness of the market in the country.
• Identify growth segments and opportunities in each industry sector within the country.
• Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
• Analyze the competitiveness of the market in the country and identify hotspots.
• Develop strategies based on the latest product, brand, expansion and research and development news in the country.
• Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
• Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

1 Table of Contents 2
1.1 List of Tables 11
1.2 List of Figures 14
2 Introduction 17
2.1 What Is This Report About? 17
2.2 Definitions 17
2.2.1 Wound Care Management 17
3 Healthcare Sector Review 19
3.1 Healthcare Sector 19
3.2 Healthcare Expenditure 19
3.3 Healthcare Infrastructure 23
3.3.1 Healthcare Personnel Data 23
3.3.2 Healthcare Facilities Data 25
3.4 Healthcare Policy 30
4 Wound Care Management in Germany 31
4.1 Wound Care Management Overall Revenues (2000-2012) 31
4.2 Wound Care Management Overall Volume (2000-2012) 37
4.3 Wound Care Management Overall Company Shares (2005-2006) 40
5 Wound Closure Devices in Germany 41
5.1 Wound Closure Devices Overall Revenues (2000-2012) 41
5.1.1 Skin Closure Devices Overall Revenues (2000-2012) 45
5.1.2 Hemostats Overall Revenues (2000-2012) 47
5.1.3 Tissue Sealants Overall Revenues (2000-2012) 49
5.2 Wound Closure Devices Overall Volume (2000-2012) 51
5.2.1 Skin Closure Devices Overall Volume (2000-2012) 53
5.2.2 Tissue Sealants Overall Volume (2000-2012) 55
5.2.3 Hemostats Overall Volume (2000-2012) 57
5.3 Wound Closure Devices Average Price (2000-2012) 59
5.3.1 Hemostats Average Price (2000-2012) 59
5.4 Wound Closure Devices Distribution Share (2005-2006) 65
5.5 Wound Closure Devices Company Share (2005-2006) 66
6 Ostomy in Germany 67
6.1 Ostomy Overall Revenue (2000-2012) 67
6.2 Ostomy Overall Volume (2000-2012) 69
6.3 Ostomy Average Price (2000-2012) 71
6.4 Ostomy Distribution Share (2005-2006) 73
6.5 Ostomy Company Share (2005-2006) 74
7 Advance Wound Management in Germany 75
7.1 Advanced Wound Management Overall Revenue (2000-2012) 75
7.2 Advanced Wound Management Overall Volume (2000-2012) 77
7.3 Advanced Wound Management Average Price (2000-2012) 79
7.4 Advanced Wound Management Distribution Share (2005-2006) 81
7.5 Advanced Wound Management Company Share (2005-2006) 82
8 Traditional Wound Management in Germany 83
8.1 Traditional Wound Management Overall Revenue (2000-2012) 83
8.2 Traditional Wound Management Overall Volume (2000-2012) 85
8.3 Traditional Wound Management Average Price (2000-2012) 87
8.4 Traditional Wound Management Distribution Share (2005-2006) 89
8.5 Traditional Wound Management Company Share (2005-2006) 90
9 Compression Therapy in Germany 91
9.1 Compression Therapy Overall Revenue (2000-2012) 91
9.2 Compression Therapy Overall Volume (2000-2012) 93
9.3 Compression Therapy Average Price (2000-2012) 95
9.4 Compression Therapy Distribution Share (2005-2006) 97
9.5 Compression Therapy Company Share (2005-2006) 98
10 The HARTMANN GROUP Company Profile 99
10.1 Company Overview 99
10.2 Business Overview 99
10.2.1 Incontinence Management 99
10.2.2 Operating Theater Management 99
10.2.3 Other GROUP Activities 100
10.2.4 Wound Management 100
10.2.5 Products 101
10.2.6 History 102
10.3 Value Chain Analysis 104
10.3.1 Manufacturing 104
10.3.2 Product Development 104
10.3.3 Sales and Marketing 105
10.4 SWOT Analysis 105
10.4.1 HARTMANN GROUP Strengths 105
10.4.2 HARTMANN GROUP Weaknesses 106
10.4.3 HARTMANN GROUP Opportunities 106
10.4.4 HARTMANN GROUP Threats 107
10.5 Financial and Operational Review 109
10.6 Locations And Subsidiaries 111
10.7 Recent Developments 113
10.7.1 Mar 17, 2008: Hartmann Declares 2007 Results 113
10.7.2 Jan 29, 2008: HARTMANN Establishes New Subsidiary In Siberia 114
10.7.3 Jan 11, 2008: HARTMANN Launches New Subsidiary In Ulm 115
10.7.4 Aug 10, 2007: Hartmann Reports H1 2007 Results 115
11 Ethicon, Inc. Company Profile 117
11.1 Company Overview 117
11.2 Business Overview 117
11.2.1 Products 118
11.3 Locations And Subsidiaries 119
11.4 Financial Deals Landscape 121
11.4.1 Edwards Lifesciences Acquires CardioVations Product Line From ETHICON 121
11.4.2 Musculoskeletal Transplant Signs Marketing Agreement With ETHICON 123
11.4.3 ETHICON Acquires Vascular Control Systems 124
11.4.4 Datascope Acquires Endoscopic Vessel Harvesting Business From ETHICON 125
12 Coloplast A/S Company Profile 128
12.1 Company Overview 128
12.2 Business Overview 128
12.2.1 Medical Care 128
12.2.2 Overview 128
12.2.3 Major Products and Services 129
12.2.4 History 129
12.3 Value Chain Analysis 131
12.3.1 Manufacturing 131
12.3.2 Product Development 132
12.3.3 Sales and Marketing 133
12.4 SWOT Analysis 134
12.4.1 Coloplast A/S Strengths 134
12.4.2 Coloplast A/S Weaknesses 135
12.4.3 Coloplast A/S Opportunities 135
12.4.4 Coloplast A/S Threats 136
12.5 Financial and Operational Review 137
12.5.1 Financial Statements 137
12.6 Financial Ratios 138
12.7 Share Holding Structure 139
12.8 Locations And Subsidiaries 139
12.9 Financial Deals Landscape 142
12.9.1 Coloplast Sells Brachytherapy Business To Core Oncology 142
12.9.2 Coloplast Signs Distribution Agreement With Carbon Medical Technologies 143
12.9.3 Granville Baird Capital Partners Advisors Acquires Coloplast’s Business Unit 145
12.9.4 McKesson Corporation Acquires Sterling Medical Services 146
12.9.5 Coloplast Acquires Surgical Urology And Clinical And Consumer Healthcare Business Segments Of Mentor 148
12.10 Recent Developments 151
12.10.1 Apr 07, 2008: Coloplast Plans To Invest EUR100 Million In Hungary 151
12.10.2 Feb 19, 2008: Coloplast Declares Q1 Fiscal 2008 Results 151
12.10.3 Nov 20, 2007: Coloplast Declares Fiscal 2007 Results 153
12.10.4 Aug 16, 2007: Coloplast Declares Nine Months Ended 2007 Results 155
12.10.5 May 15, 2007: Colplast Declares H1 2007 Results 156
12.10.6 Feb 08, 2007: Coloplast Declares Q1 Fiscal 2007 Results 158
12.10.7 Dec 13, 2006: Coloplast Appoints New Chairman 159
12.10.8 Nov 15, 2006: Coloplast Declares Fiscal 2006 Results 159
13 Smith & Nephew Plc Company Profile 161
13.1 Company Overview 161
13.2 Business Overview 161
13.2.1 Advanced Wound Management 161
13.2.2 Endoscopy 162
13.2.3 Reconstruction 162
13.2.4 Trauma and Clinical Therapies 163
13.2.5 Products 164
13.2.6 History 165
13.3 Value Chain Analysis 169
13.3.1 Manufacturing 169
13.3.2 Product Development 170
13.3.3 Sales and Marketing 171
13.4 SWOT Analysis 171
13.4.1 Smith & Nephew Plc Strengths 172
13.4.2 Smith & Nephew Plc Weaknesses 172
13.4.3 Smith & Nephew Plc Opportunities 173
13.4.4 Smith & Nephew Plc Threats 173
13.5 Financial and Operational Review 174
13.6 Locations And Subsidiaries 175
13.7 Financial Deals Landscape 177
13.7.1 Smith & Nephew Endoscopy Sells Its Vascular Business To InaVein 177
13.7.2 Smith & Nephew Signs An Agreement With Universal Hospital Services 178
13.7.3 Smith & Nephew Acquires Plus Orthopedics Holding 179
13.7.4 Smith & Nephew And Teknimed Enter Into Distribution Agreement 180
13.7.5 Smith & Nephew Acquires BlueSky Medical Group 181
13.7.6 Smith & Nephew Enters Into An Agreement With Covalon 182
13.7.7 Smith & Nephew Signs An Agreement With UDL Laboratories 183
13.7.8 Nexa Orthopedics Signs An Agreement With Smith & Nephew 184
13.7.9 Smith & Nephew Acquires Osteobiologics 184
13.7.10 Smith & Nephew And Q-MED Enter Into Licensing Agreement 185
13.7.11 Smith & Nephew Completes Sale Of 50% Interest In BSN Medical To Montagu Private Equity 187
13.7.12 ArthroCare Enters Into Licensing Agreement With Smith & Nephew 188
13.7.13 Smith & Nephew Signs Licensing Agreement With Alexandria Research Technologies 189
13.7.14 Smith & Nephew Signs An Agreement With ORTHOsoft 190
13.7.15 Osteotech And Smith & Nephew Enter Into Processing And Distribution Agreement 191
13.7.16 Smith & Nephew Acquires VERSAJET From HydroCision 192
13.7.17 Smith & Nephew Terminates Acquisition Of Biomet 193
13.8 Recent Developments 194
13.8.1 Apr 02, 2008: Smith & Nephew Declares Second Interim Dividend 194
13.8.2 Apr 02, 2008: Smith & Nephew Reports 2007 Results 194
13.8.3 Mar 23, 2008: Smith & Nephew, Corin Battle To Win Over America’s Hip Generation 195
13.8.4 Feb 29, 2008: Smith & Nephew Appoints SVP, GM 196
13.8.5 Feb 20, 2008: Smith & Nephew and Synthes Settle Patent Dispute For Trochanteric Fixation Nails 197
13.8.6 Oct 22, 2007: Smith & Nephew Declares Interim Dividend 197
13.8.7 May 03, 2007: Smith & Nephew Appoints New CEO 197
13.9 Smith & Nephew Plc Pipeline Products 199
13.9.1 R3 Modular resurfacing Acetabular system 199
13.9.2 R3 Ceramic-on-ceramic Acetabular System 199
14 Covidien Ltd./Tyco Healthcare Company Profile 200
14.1 Company Overview 200
14.2 Business Overview 200
14.2.1 Imaging Solutions 200
14.2.2 Medical Devices 201
14.2.3 Medical Supplies 201
14.2.4 Pharmaceutical Products 202
14.2.5 Retail Products 202
14.2.6 Products 203
14.2.7 History 204
14.3 Value Chain Analysis 205
14.3.1 Manufacturing 205
14.3.2 Product Development 205
14.3.3 Sales and Marketing 207
14.4 SWOT Analysis 207
14.4.1 Covidien Ltd./Tyco Healthcare Strengths 208
14.4.2 Covidien Ltd./Tyco Healthcare Weaknesses 208
14.4.3 Covidien Ltd./Tyco Healthcare Opportunities 209
14.4.4 Covidien Ltd./Tyco Healthcare Threats 210
14.5 Financial and Operational Review 211
14.5.1 Financial Statements 211
14.5.2 Financial Ratios 212
14.6 Locations And Subsidiaries 213
14.7 Financial Deals Landscape 215
14.7.1 Covidien Signs An Agreement With Allergan 215
14.7.2 Covidien Acquires Scandius Biomedical 216
14.7.3 Covidien International Finance Completes Private Placement Of $2,750 Million 217
14.7.4 Covidien And BioSynthema Enter Into Licensing Agreement 219
14.7.5 Integra LifeSciences Acquires Assets Of Radionics Division From Covidien 220
14.7.6 Covidien To Sell European Incontinence Business 223
14.7.7 Covidien To Acquire Tissue Science Laboratories 224
14.8 Recent Developments 226
14.8.1 Mar 28, 2008: Covidien Spends $760,000 Lobbying Federal Government In 2007 226
14.8.2 Mar 18, 2008: Covidien Declares Quarterly Dividend 226
14.8.3 Feb 21, 2008: Covidien Gests Favorable Decision In Patent Litigation Case 226
14.8.4 Feb 07, 2008: Covidien Declares Q1 Fiscal 2008 Results 226
14.8.5 Jan 15, 2008: Covidien Declares Quarterly Dividend 228
14.8.6 Jan 10, 2008: Covidien To Declare Q1 Fiscal 2008 Results 228
14.8.7 Dec 06, 2007: Covidien Reports Q4 Fiscal 2007 Results 229
14.8.8 Oct 04, 2007: Covidien And NewSouth Innovations Collaborate To Develop Novel Imaging Agent 231
14.8.9 Sep 28, 2007: Covidien Declares Quarterly Dividend 231
14.8.10 Aug 09, 2007: Covidien Declares Q3 Fiscal 2007 Results 231
14.9 Covidien Ltd./Tyco Healthcare Pipeline Products 233
14.9.1 PleuraSeal Lung Sealant System 233
14.9.2 Sandman Intro CPAP Device 234
15 Regulation System 236
15.1 Medical Equipment Approval Process 236
15.1.1 Classification of Medical Devices 236
15.2 Conformity Assessment Process 245
15.2.1 Class I devices 245
15.2.2 Class IIa devices 246
15.2.3 Class IIb devices 247
15.2.4 Class III devices 248
15.3 Post Market Surveillance 248
16 Pricing and Reimbursement 249
16.1 SHI 249
16.1.1 Private Health Insurance 249
16.1.2 Diagnosis Related Groups (DRG) 249
17 Distribution Structure 250
18 APPENDIX 251
18.1 Global Markets Direct Research Methodology 251
18.2 Coverage 252
18.3 Secondary Research 252
18.4 Primary Research 253
18.5 Models 253
18.6 Forecasts 254
18.7 Expert Panels 254
18.8 Currency Conversion 255
18.9 Contact Us 256
18.10 Disclaimer 256



1.1 List of Tables
Table 1: Healthcare Personnel by Region in Germany, 2004 23
Table 2: Doctors by Specialty in Germany, 2000-2004 24
Table 3: Hospitals by Region in Germany, 2004 25
Table 4: Hospital Beds by Region in Germany, 2004 26
Table 5: Rehabilitation Centers by Region in Germany, 2004 27
Table 6: Rehabilitation Center Beds by Region in Germany, 2004 28
Table 7: Discharges by Diagnosis in Germany, 2004 29
Table 8: Wound Care Management, Germany, Overall Revenues ($ mn), 2000-2012 31
Table 9: Wound Care Management, Germany, Overall Revenues ($ mn), Historic, 2000-2007 32
Table 10: Wound Care Management, Germany, Overall Revenues ($ mn), Forecast, 2007-2012 33
Table 11: Wound Care Management, Germany, Category Revenues ($ mn), 2000-2012 34
Table 12: Wound Care Management, Germany, Category Revenues ($ mn), Historic, 2000-2007 35
Table 13: Wound Care Management, Germany, Category Revenues ($ mn), Forecast, 2007-2012 36
Table 14: Wound Care Management, Germany, Category Volume (Units), 2000-2012 37
Table 15: Wound Care Management, Germany, Category Volume (Units), Historic, 2000-2007 38
Table 16: Wound Care Management, Germany, Category Volume (Units), Forecast, 2007-2012 39
Table 17: Wound Care Management in Germany, Overall, Company Share by Revenue ($ mn), 2005-2006 40
Table 18: Wound Closur e Devices, Germany, Overall Revenues ($ mn), Historic, 2000-2007 41
Table 19: Wound Closure Devices, Germany, Overall Revenues ($ mn), Forecast, 2007-2012 42
Table 20: Wound Closure Devices, Germany, Revenue by Segment ($ mn), Historic, 2000-2007 43
Table 21: Wound Closure Devices, Germany, Revenue by Segment ($ mn), Forecast, 2007-2012 44
Table 22: Skin Closure Devices, Germany, Overall Revenues ($ mn), Historic, 2000-2007 45
Table 23: Skin Closure Devices, Germany, Overall Revenues ($ mn), Forecast, 2007-2012 46
Table 24: Hemostats, Germany, Overall Revenues ($ mn), Historic, 2000-2007 47
Table 25: Hemostats, Germany, Overall Revenues ($ mn), Forecast, 2007-2012 48
Table 26: Tissue Sealants, Germany, Overall Revenues ($ mn), Historic, 2000-2007 49
Table 27: Tissue Sealants, Germany, Overall Revenues ($ mn), Forecast, 2007-2012 50
Table 28: Wound Closure Devices, Germany, Overall Volume (Units), Historic, 2000-2007 51
Table 29: Wound Closure Devices, Germany, Overall Volume (Units), Forecast, 2007-2012 52
Table 30: Skin Closure Devices, Germany, Overall Volume (Units), Historic, 2000-2007 53
Table 31: Skin Closure Devices, Germany, Overall Volume (Units), Forecast, 2007-2012 54
Table 32: Tissue Sealants, Germany, Overall Volume (Units), Historic, 2000-2007 55
Table 33: Tissue Sealants, Germany, Overall Volume (Units), Forecast, 2007-2012 56
Table 34: Hemostats, Germany, Overall Volume (Units), Historic, 2000-2007 57
Table 35: Hemostats, Germany, Overall Volume (Units), Forecast, 2007-2012 58
Table 36: Hemostats, Germany, Average Price ($), Historic, 2000-2007 59
Table 37: Hemostats, Germany, Average Price ($), Forecast, 2007-2012 60
Table 38: Tissue Sealants, Germany, Average Price ($), Historic, 2000-2007 61
Table 39: Tissue Sealants, Germany, Average Price ($), Forecast, 2007-2012 62
Table 40: Skin Closure Devices, Germany, Average Price ($), Historic, 2000-2007 63
Table 41: Skin Closure Devices, Germany, Average Price ($), Forecast, 2007-2012 64
Table 42: Wound Closure Devices, Germany, Distribution Share by Revenue ($ mn) , 2005-2006 65
Table 43: Wound Closure Devices, Germany, Company Share by Revenue ($ mn) , 2005-2006 66
Table 44: Ostomy, Germany, Overall Revenues ($ mn), Historic, 2000-2007 67
Table 45: Ostomy, Germany, Overall Revenues ($ mn), Forecast, 2007-2012 68
Table 46: Ostomy, Germany, Overall Volume (Units), Historic, 2000-2007 69
Table 47: Ostomy, Germany, Overall Volume (Units), Forecast, 2007-2012 70
Table 48: Ostomy, Germany, Average Price ($), Historic, 2000-2007 71
Table 49: Ostomy, Germany, Average Price ($), Forecast, 2007-2012 72
Table 50: Ostomy, Germany, Distribution Share by Revenue ($ mn) , 2005-2006 73
Table 51: Ostomy, Germany, Company Share by Revenue ($ mn), 2005-2006 74
Table 52: Advanced Wound Management, Germany, Overall Revenues ($ mn), Historic, 2000-2007 75
Table 53: Advanced Wound Management, Germany, Overall Revenues ($ mn), Forecast, 2007-2012 76
Table 54: Advanced Wound Management, Germany, Overall Volume (Units), Historic, 2000-2007 77
Table 55: Advanced Wound Management, Germany, Overall Volume (Units), Forecast, 2007-2012 78
Table 56: Advanced Wound Management, Germany, Average Price ($), Historic, 2000-2007 79
Table 57: Advanced Wound Management, Germany, Average Price ($), Forecast, 2007-2012 80
Table 58: Advanced Wound Management, Germany, Distribution Share by Revenue ($ mn) , 2005-2006 81
Table 59: Advanced Wound Management, Germany, Company Share by Revenue ($ mn) , 2005-2006 82
Table 60: Traditional Wound Management, Germany, Overall Revenues ($ mn), Historic, 2000-2007 83
Table 61: Traditional Wound Management, Germany, Overall Revenues ($ mn), Forecast, 2007-2012 84
Table 62: Traditional Wound Management, Germany, Overall Volume (Units), Historic, 2000-2007 85
Table 63: Traditional Wound Management, Germany, Overall Volume (Units), Forecast, 2007-2012 86
Table 64: Traditional Wound Management, Germany, Average Price ($), Historic, 2000-2007 87
Table 65: Traditional Wound Management, Germany, Average Price ($), Forecast, 2007-2012 88
Table 66: Traditional Wound Management, Germany, Distribution Share by Revenue ($ mn) , 2005-2006 89
Table 67: Traditional Wound Management, Germany, Company Share by Revenue ($ mn) , 2005-2006 90
Table 68: Compression Therapy, Germany, Overall Revenues ($ mn), Historic, 2000-2007 91
Table 69: Compression Therapy, Germany, Overall Revenues ($ mn), Forecast, 2007-2012 92
Table 70: Compression Therapy, Germany, Overall Volume (Units), Historic, 2000-2007 93
Table 71: Compression Therapy, Germany, Overall Volume (Units), Forecast, 2007-2012 94
Table 72: Compression Therapy, Germany, Average Price ($), Historic, 2000-2007 95
Table 73: Compression Therapy, Germany, Average Price ($), Forecast, 2007-2012 96
Table 74: Compression Therapy, Germany, Distribution Share by Revenue ($ mn) , 2005-2006 97
Table 75: Compression Therapy, Germany, Company Share by Revenue ($ mn) , 2005-2006 98
Table 76: HARTMANN GROUP, SWOT Analysis , 2006 105
Table 77: HARTMANN GROUP, Financial Statements, Euro Thousand, 2002-2006 109
Table 78: HARTMANN GROUP, Financial Ratios, Euro Thousand, 2002-2006 110
Table 79: HARTMANN GROUP, Subsidiaries 111
Table 80: HARTMANN GROUP, Subsidiaries (Contd.) 112
Table 81: Ethicon, Inc., Other Locations 119
Table 82: Ethicon, Inc., Subsidiaries 120
Table 83: Coloplast A/S, SWOT Analysis , 2007 134
Table 84: Coloplast A/S, Financial Statements, DKK Million, 2003-2007 137
Table 85: Coloplast A/S, Financial Ratios, DKK Million, 2003-2007 138
Table 86: Coloplast A/S, Share Holding Structure 139
Table 87: Coloplast A/S, Other Locations 139
Table 88: Coloplast A/S, Subsidiaries 140
Table 89: Coloplast A/S, Subsidiaries (Contd.) 141
Table 90: Smith & Nephew Plc, SWOT Analysis, 2006 171
Table 91: Smith & Nephew Plc, Financial Statements, USD Million, 2002-2006 174
Table 92: Smith & Nephew Plc, Financial Ratios, USD Million, 2002-2006 175
Table 93: Smith & Nephew Plc, Other Locations 176
Table 94: Covidien Ltd./Tyco Healthcare, SWOT Analysis, 2007 207
Table 95: Covidien Ltd./Tyco Healthcare, Financial Statements, USD Million, 2003-2007 211
Table 96: Covidien Ltd./Tyco Healthcare, Financial Ratios, USD Million, 2003-2007 212
Table 97: Covidien Ltd./Tyco Healthcare, Other Locations 213
Table 98: Covidien Ltd./Tyco Healthcare, Subsidiaries 214
Table 99: Currency Conversion from USD to Local Currency at 2007 Constant Rate 255



1.2 List of Figures
Figure 1: Healthcare Structure in Germany, 2000 - 2006 20
Figure 2: Healthcare Expenditure Sources in Germany, 2003 21
Figure 3: Healthcare Financing Framework in Germany, 2007 22
Figure 4: Wound Care Management, Germany, Overall Revenues ($ mn), 2000-2012 31
Figure 5: Wound Care Management, Germany, Overall Revenues ($ mn), Historic, 2000-2007 32
Figure 6: Wound Care Management, Germany, Overall Revenues ($ mn), Forecast, 2007-2012 33
Figure 7: Wound Care Management, Germany, Category Revenues ($ mn), 2000-2012 34
Figure 8: Wound Care Management, Germany, Category Revenues ($ mn), Historic, 2000-2007 35
Figure 9: Wound Care Management, Germany, Category Revenues ($ mn), Forecast, 2007-2012 36
Figure 10: Wound Care Management, Germany, Category Volume (Units), 2000-2012 37
Figure 11: Wound Care Management, Germany, Category Volume (Units), Historic, 2000-2007 38
Figure 12: Wound Care Management, Germany, Category Volume (Units), Forecast, 2007-2012 39
Figure 13: Wound Care Management in Germany, Overall, Company Share (%), 2006 40
Figure 14: Wound Closure Devices, Germany, Overall Revenues ($ mn), Historic, 2000-2007 41
Figure 15: Wound Closure Devices, Germany, Overall Revenues ($ mn), Forecast, 2007-2012 42
Figure 16: Wound Closure Devices, Germany, Revenue by Segment ($ mn), Historic, 2000-2007 43
Figure 17: Wound Closure Devices, Germany, Revenue by Segment ($ mn), Forecast, 2007-2012 44
Figure 18: Skin Closure Devices, Germany, Overall Revenues ($ mn), Historic, 2000-2007 45
Figure 19: Skin Closure Devices, Germany, Overall Revenues ($ mn), Forecast, 2007-2012 46
Figure 20: Hemostats, Germany, Overall Revenues ($ mn), Historic, 2000-2007 47
Figure 21: Hemostats, Germany, Overall Revenues ($ mn), Forecast, 2007-2012 48
Figure 22: Tissue Sealants, Germany, Overall Revenues ($ mn), Historic, 2000-2007 49
Figure 23: Tissue Sealants, Germany, Overall Revenues ($ mn), Forecast, 2007-2012 50
Figure 24: Wound Closure Devices, Germany, Overall Volume (Units), Historic, 2000-2007 51
Figure 25: Wound Closure Devices, Germany, Overall Volume (Units), Forecast, 2007-2012 52
Figure 26: Skin Closure Devices, Germany, Overall Volume (Units), Historic, 2000-2007 53
Figure 27: Skin Closure Devices, Germany, Overall Volume (Units), Forecast, 2007-2012 54
Figure 28: Tissue Sealants, Germany, Overall Volume (Units), Historic, 2000-2007 55
Figure 29: Tissue Sealants, Germany, Overall Volume (Units), Forecast, 2007-2012 56
Figure 30: Hemostats, Germany, Overall Volume (Units), Historic, 2000-2007 57
Figure 31: Hemostats, Germany, Overall Volume (Units), Forecast, 2007-2012 58
Figure 32: Hemostats, Germany, Average Price ($), Historic, 2000-2007 59
Figure 33: Hemostats, Germany, Average Price ($), Forecast, 2007-2012 60
Figure 34: Tissue Sealants, Germany, Average Price ($), Historic, 2000-2007 61
Figure 35: Tissue Sealants, Germany, Average Price ($), Forecast, 2007-2012 62
Figure 36: Skin Closure Devices, Germany, Average Price ($), Historic, 2000-2007 63
Figure 37: Skin Closure Devices, Germany, Average Price ($), Forecast, 2007-2012 64
Figure 38: Wound Closure Devices, Germany, Distribution Share (%), 2006 65
Figure 39: Wound Closure Devices, Germany, Company Share (%), 2006 66
Figure 40: Ostomy, Germany, Overall Revenues ($ mn), Historic, 2000-2007 67
Figure 41: Ostomy, Germany, Overall Revenues ($ mn), Forecast, 2007-2012 68
Figure 42: Ostomy, Germany, Overall Volume (Units), Historic, 2000-2007 69
Figure 43: Ostomy, Germany, Overall Volume (Units), Forecast, 2007-2012 70
Figure 44: Ostomy, Germany, Average Price ($), Historic, 2000-2007 71
Figure 45: Ostomy, Germany, Average Price ($), Forecast, 2007-2012 72
Figure 46: Ostomy, Germany, Company Share (%), 2006 74
Figure 47: Advanced Wound Management, Germany, Overall Revenues ($ mn), Historic, 2000-2007 75
Figure 48: Advanced Wound Management, Germany, Overall Revenues ($ mn), Forecast, 2007-2012 76
Figure 49: Advanced Wound Management, Germany, Overall Volume (Units), Historic, 2000-2007 77
Figure 50: Advanced Wound Management, Germany, Overall Volume (Units), Forecast, 2007-2012 78
Figure 51: Advanced Wound Management, Germany, Average Price ($), Historic, 2000-2007 79
Figure 52: Advanced Wound Management, Germany, Average Price ($), Forecast, 2007-2012 80
Figure 53: Advanced Wound Management, Germany, Distribution Share (%), 2006 81
Figure 54: Advanced Wound Management, Germany, Company Share (%), 2006 82
Figure 55: Traditional Wound Management, Germany, Overall Revenues ($ mn), Historic, 2000-2007 83
Figure 56: Traditional Wound Management, Germany, Overall Revenues ($ mn), Forecast, 2007-2012 84
Figure 57: Traditional Wound Management, Germany, Overall Volume (Units), Historic, 2000-2007 85
Figure 58: Traditional Wound Management, Germany, Overall Volume (Units), Forecast, 2007-2012 86
Figure 59: Traditional Wound Management, Germany, Average Price ($), Historic, 2000-2007 87
Figure 60: Traditional Wound Management, Germany, Average Price ($), Forecast, 2007-2012 88
Figure 61: Traditional Wound Management, Germany, Distribution Share (%), 2006 89
Figure 62: Traditional Wound Management, Germany, Company Share (%), 2006 90
Figure 63: Compression Therapy, Germany, Overall Revenues ($ mn), Historic, 2000-2007 91
Figure 64: Compression Therapy, Germany, Overall Revenues ($ mn), Forecast, 2007-2012 92
Figure 65: Compression Therapy, Germany, Overall Volume (Units), Historic, 2000-2007 93
Figure 66: Compression Therapy, Germany, Overall Volume (Units), Forecast, 2007-2012 94
Figure 67: Compression Therapy, Germany, Average Price ($), Historic, 2000-2007 95
Figure 68: Compression Therapy, Germany, Average Price ($), Forecast, 2007-2012 96
Figure 69: Compression Therapy, Germany, Distribution Share (%), 2006 97
Figure 70: Compression Therapy, Germany, Company Share (%), 2006 98
Figure 71: HARTMANN GROUP, Value Chain Analysis 104
Figure 72: Coloplast A/S, Value Chain Analysis 131
Figure 73: Smith & Nephew Plc, Value Chain Analysis 169
Figure 74: Covidien Ltd./Tyco Healthcare, Value Chain Analysis 205
Figure 75: Flowchart for Classification of Non-invasive Devices in Germany, 2007 237
Figure 76: Flowchart for Classification of Invasive Devices in Germany, 2007 238
Figure 77: Flowchart for Classification of Invasive Devices in Germany, 2007 239
Figure 78: Classification of Invasive Devices in Germany, 2007 240
Figure 79: Classification of Invasive Devices in Germany, 2007 241
Figure 80: Flowchart for Classification of Active Devices in Germany, 2007 242
Figure 81: Flowchart for Classification of Active Devices in Germany, 2007 243
Figure 82: Flowchart for Classification of Devices except Non-invasive, Invasive and Active Devices in Germany, 2007 244
Figure 83: Conformity Assessment of Class-I Medical Devices in Germany, 2007 245
Figure 84: Conformity Assessment of Class-IIa Medical Devices in Germany, 2007 246
Figure 85: Conformity Assessment of Class-IIb Medical Devices in Germany, 2007 247
Figure 86: Conformity Assessment of Class-III Medical Devices in Germany, 2007 248
Figure 87: Global Markets Direct Methodology 251